(Q37781442)

23 August 2017

title

Medical management of refractory status epilepticus (English)

1 reference

23 August 2017

Medical Management of Refractory Status Epilepticus (English)

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

20 June 2024

1 reference

James Owens

1

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20727487

20 June 2024

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1071909110000653?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

https://api.elsevier.com/content/article/PII:S1071909110000653?httpAccept=text/plain

20 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Seminars in pediatric neurology

20 June 2024

published in

1 reference

23 August 2017

volume

17

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

176-181

1 reference

Treatment of refractory status epilepticus: literature review and a proposed protocol

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Refractory status epilepticus

20 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

The management of refractory status epilepticus: an update

20 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

EFNS guideline on the management of status epilepticus.

20 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Prolonged seizures and cellular injury: understanding the connection

20 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Refractory status epilepticus: a prospective observational study

20 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

20 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review

20 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study

20 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours

20 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit

20 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Predictors of functional disability and mortality after status epilepticus

20 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Treatment delay and the risk of prolonged status epilepticus

20 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Psychogenic nonepileptic seizures: review and update

20 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Psychogenic nonepileptic seizures

20 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Recognition of nonepileptic events.

20 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

The differential diagnosis of epilepsy: a critical review

20 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment

20 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus

20 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Refractory status epilepticus: effect of treatment aggressiveness on prognosis

20 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons

20 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

The neurobiology of antiepileptic drugs

20 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Intravenous valproate treatment of generalized nonconvulsive status epilepticus

20 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients

20 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?

20 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial

20 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

20 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus

20 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Levetiracetam in children with refractory status epilepticus

20 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

The use of topiramate in refractory status epilepticus

20 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Topiramate reduces neuronal injury after experimental status epilepticus

20 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Effect of topiramate on cognitive function and single units from hippocampal place cells following status epilepticus

20 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects.

20 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide

20 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis.

20 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Midazolam and pentobarbital for refractory status epilepticus

20 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Neurologic outcomes of pediatric epileptic patients with pentobarbital coma

20 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Barbiturate inhibition of lymphocyte function. Differing effects of various barbiturates used to induce coma.

20 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury

20 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Prolongation of midazolam half-life after sustained infusion for status epilepticus.

20 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Status epilepticus: clinical analysis of a treatment protocol based on midazolam and phenytoin

20 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

High-dose midazolam therapy for refractory status epilepticus in children.

20 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus

20 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus

20 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Treatment options for status epilepticus

20 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Propofol and thiopental for refractory status epilepticus in children

20 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience

20 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Refractory status epilepticus in children: when do we stop treatment?

20 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

Refractory status epilepticus: frequency, risk factors, and impact on outcome

20 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.SPEN.2010.06.006

20 June 2024

Identifiers

1 reference

23 August 2017

1 reference